The effect of a 18 bp deletion/insertion variant of VEGF gene on the FMF development


Sezer O., NURSAL A. F., Kuruca Şahbazoğlu N., YİĞİT S.

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, cilt.42, sa.4, ss.296-307, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42 Sayı: 4
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1080/15257770.2022.2127766
  • Dergi Adı: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Chemical Abstracts Core, Chimica, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.296-307
  • Anahtar Kelimeler: Familial Mediterranean Fever, Vascular Endothelial Growth Factor, Insertion, Deletion, Variant, PCR, ENDOTHELIAL GROWTH-FACTOR, POLYMORPHISM, COMPLICATIONS, INFLAMMATION, EXPRESSION, HYPOXIA, DISEASE, CELLS
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objective: Familial Mediterranean fever (FMF) is one of the most common inherited autoinflammatory diseases. Angiogenesis is a feature of inflammatory activation and part of pathogenic processes in autoimmune diseases. Therefore, this study aimed to investigate the role of the Vascular endothelial growth factor (VEGF) gene insertion/deletion (I/D) functional variant in FMF Turkish patients. Methods: MEFV gene mutations were detected in all patients. The FMF patients (N:105) and the healthy controls (N:100) were genotyped for the VEGF I/D variant using PCR followed by agarose gel electrophoresis. The results were statistically analyzed by calculating the odds ratios (OR) and their 95% confidence intervals (95% CI) using the chi(2)-tests. Results: The mean age of patients was 25.46 +/- 10.09. Fifty-nine patients (56.2%) had two or more MEFV gene mutations. The most common MEFV mutation was M694V/M694V. The VEGF I/D variant genotype distribution exhibited a statistically significant difference between the patients and the controls. VEGF I/D genotype was higher in controls compared to patients, while D/D genotype was higher in patients compared to the controls (p = 0.003, p = 0.013, respectively). When we examined the clinical findings, joint pain was more common in patients with VEGF D/D and I/D genotypes compared to I/I genotype (p = 0.043). Although not statistically significant, the most common genotype in patients with two or more MEFV mutations was VEGF D/D (28.6%). Conclusion: The results provided evidence supporting that the D/D genotype of the VEGF I/D variant is associated with an increased risk of FMF in a group of Turkish populations.